Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
A recent regulatory filing has revealed that Robert F. Werner, the Chief Accounting Officer for Twist Bioscience Corp (NASDAQ:TWST), has engaged in a significant sale of company shares. The transaction, which occurred on May 8, 2026, involved the disposal of 4,961 shares of common stock at an individual price of $56.881 per share. This move resulte…
Kade Ross, the Chief Information Officer of Bandwidth Inc. (NASDAQ: BAND), has completed the sale of 20,000 shares of Class A Common Stock. The transactions, which took place on May 11, 2026, totaled approximately $1,031,256. These sales were carried out under a Rule 10b5-1 trading plan that was established by Mr. Ross on November 24, 2025.
Greenland Energy Co (NASDAQ:GLND) has seen notable insider activity following a period of significant share price depreciation. Melanie Sue Furlan, a director at the company, executed a purchase of 33,330 shares of common stock on May 8, 2026. The transaction, valued at a total of $100,656, comes at a time when the equity is trading near its 52-wee…
Kura Oncology posted $5.8 million in net product revenue from KOMZIFTI in the first full quarter since commercialization, showing strong physician adoption and payer coverage. The company is advancing multiple clinical trials for ziftomenib in AML, with anticipated 2026 data readouts supporting its broad use. The robust cash position and collaborat…
CSX Corporation's Board of Directors has approved a quarterly dividend of $0.14 per share, payable on June 15, 2026, to shareholders of record as of May 29, 2026. CSX is a major transportation company specializing in rail, intermodal, and rail-to-truck transload services across various sectors including energy, industrial, construction, agricultura…
Kyverna Therapeutics announced the initiation of a rolling Biologics License Application (BLA) submission to the FDA for its CAR T-cell therapy, mivocabtagene autoleucel (miv-cel), targeting stiff person syndrome (SPS). The company gained FDA alignment on the regulatory path following a positive pre-BLA meeting. Recent trial data demonstrated robus…
Maze Therapeutics announced positive topline Phase 2 trial data for MZE829 in APOL1-mediated kidney disease (AMKD), demonstrating clinical proof-of-concept and supporting advancement to a pivotal trial. It plans to start Phase 2 trials for MZE782 in phenylketonuria (PKU) and chronic kidney disease (CKD) in 2026, with topline data expected in 2027. …
BIO-key International's Nasdaq-listed shares (BKYI) will be suspended as of May 12, 2026, due to the stock price failing to maintain Nasdaq's $1 minimum bid price for the required duration and delays in filing its annual report. The company will temporarily trade on the OTC Markets while seeking to restore its Nasdaq listing. Despite the suspension…
Nkarta, Inc. reported its Q1 2026 financial results and corporate updates, highlighting progress in its NKX019 clinical trials (Ntrust-1 and Ntrust-2) for autoimmune diseases. The company secured FDA agreement for outpatient dosing, protocol amendments including re-dosing and expanded indications, and obtained multiple IRB approvals. Nkarta maintai…
OptimizeRx Corp. reported Q1 2026 revenue of $19.8 million, a 10% decrease year-on-year, but achieved a narrowed GAAP net loss of $0.5 million and increased adjusted EBITDA to $3.3 million. The company updated its fiscal year 2026 revenue guidance higher to $95-$100 million while maintaining adjusted EBITDA guidance at $21-$25 million. Subsequent t…
Verrica Pharmaceuticals reported a 51.3% year-over-year increase in dispensed YCANTH applicator units and $5.0 million revenue in Q1 2026, highlighting growing adoption of their FDA-approved treatment for molluscum. The company advanced its global Phase 3 trial enrollment for YCANTH's new use in common warts and expanded commercial launch into Japa…
Inhibikase Therapeutics announced the commencement of its pivotal Phase 3 IMPROVE-PAH clinical trial targeting Pulmonary Arterial Hypertension (PAH) with its lead candidate IKT-001. The company secured regulatory approvals across 16 countries including the US and EU, benefiting from the EMA's FAST-EU initiative to expedite trial sites activation. F…
Pacira BioSciences issued a letter to its stockholders ahead of the 2026 Annual Meeting, advocating for votes in favor of its three board nominees. The company emphasizes the nominees' extensive experience in healthcare and biopharmaceutical sectors aligned with Pacira's strategic goals, contrasted against the underqualified nominees proposed by ac…
IZEA Worldwide reported a Q1 2026 revenue of $6.6 million, an 18% decrease year-over-year, reflecting their strategic shift away from low-margin SMB accounts toward higher-value enterprise clients. Despite the revenue decline and a net loss of $0.8 million, the company launched ZED, an AI-powered marketing platform, secured new major clients, and m…
Aura Biosciences, a clinical-stage biotech company specializing in precision therapies for solid tumors, announced that its senior management will participate in two major investor conferences in May 2026 to discuss the company's developments and outlook. Live webcasts will be available and archived on the company's investor relations website.
Scandic Finance Group has introduced SNC Scandic Coin (SNC), a utility token intended for payments, access and loyalty across a range of real-world services inside the group’s ecosystem. Project representatives and documents describe a regulated framework with audited smart contracts, KYC/KYB and AML arrangements, a capped supply and a staged rollo…
Molecular Partners reports progress in its lead Radio-DARPin MP0712 with a Phase 1/2a study underway in multiple US clinical sites and initial data expected in 2026. The company unveiled an isotope-agnostic Radio-DARPin strategy enabling flexible therapeutic payloads and strengthened its financial position with CHF 79 million cash, supporting pipel…
Cytokinetics announced participation in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference. The company highlighted progress on its cardiac drug candidates, including the approved MYQORZO® (aficamten) for obstructive hypertrophic cardiomyopathy and positive Phase 3 results for aficamten in non-obstructive HCM. They continu…
A substantial liquidation of equity has been reported by Pentwater Capital Management LP and Matthew Halbower, both of whom are identified as 10% owners of Avis Budget Group, Inc. (NASDAQ:CAR). According to a recent Form 4/A filing, these reporting persons have executed transactions involving the sale of common stock and call options valued at appr…
Patrick V. Auletta, a director at Park Ohio Holdings Corp. (NASDAQ:PKOH), has completed a sale of common stock totaling approximately $178,571. The transaction occurred on May 11, 2026, involving the sale of 5,825 shares at a price point of $30.6561 per share. This move comes as Park Ohio continues to manage its financial position following recent …
Chadwick Shelly Marie, the Vice President of Finance and Chief Financial Officer at Materion Corp (NASDAQ: MTRN), conducted a series of stock transactions on May 8, 2026. The activity involved the exercise of Stock Appreciation Rights, the sale of common stock, and the disposal of shares to address tax obligations. These movements occur against a b…
South Jersey Industries, Inc. announced a cash tender offer to repurchase all outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031 at $920 per $1,000 principal amount plus accrued interest. The offer aims to refinance debt subject to market and legal conditions, with no minimum tender amount required. The tender will expi…
Apple is reportedly preparing to let iPhone users fully customize the Camera app in the upcoming iOS 27 release. According to unnamed sources, controls such as flash, exposure, timer and resolution can be repositioned or toggled on and off. The update is also said to include visual and interface changes across Siri, system search and several apps, …
Brown-Forman shares fell modestly on Tuesday after reports that the company declined a $15 billion takeover bid from rival Sazerac. Advisers informed Sazerac on Monday that the $32-a-share all-cash offer would be rejected. The offer, backed financially by Wells Fargo and Apollo Global Management, would have given Class A shareholders the option of …
Intel's shares have climbed about 100% in the last month amid media reports suggesting the company is in discussions with Apple and SK hynix about foundry services. Analysts see the potential for both advanced packaging and front-end wafer manufacturing contracts, with Deutsche Bank maintaining a Hold rating while lifting its price target to $100 b…
